Non-invasive Urinary Genomics-Based Risk Assessment for Early Urothelial Carcinoma Diagnosis

Abroad (travel likely)Recruiting

Conditions

Urothelial Carcinoma (UC) · Upper Tract Urothelial Carcinoma · UTUC · Bladder Cancer (BC)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Henan Provincial People's Hospital, Zhengzhou, Henan, China
Contact: Study coordinator (Kunpeng Shu) · kunpengshu@163.com · +8615515696659

Study leads

Zhifeng Wang, PhD
Principal Investigator
Henan Provincial People's Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

NSCLC Adenocarcinoma · Gastroesophageal Cancer (GC) · Gastric Adenocarcinoma

Abroad (travel likely)RecruitingPHASE1

Santa Rosa, United States · Washington D.C., United States

Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer

Bladder Cancer · Urothelial Carcinoma (UC) · Hematuria

Abroad (travel likely)Recruiting

Oceanside, United States · San Diego, United States

Comparison of CT and MR (VI-RADS) Imaging for Local Bladder Cancer Staging

Bladder Cancer · Urothelial Carcinoma (UC) · Muscle Invasive Bladder Cancer (MIBC)

Abroad (travel likely)Recruiting

Oslo, Norway

Adjuvant Sacituzumab Govitecan and Nivolumab in Muscle-Invasive Urothelial Carcinoma at High-Risk Recurrence

Urothelial Carcinoma · Muscle-invasive Bladder Cancer

Abroad (travel likely)RecruitingPHASE2

Orange, United States